Robert Bookstein

9.6k citations
54 papers · 8.4k · 6 hit papers · h-index 35

Impact in

  • Ophthalmology top 0.2%
    • Ocular Oncology and Treatments
  • Oncology top 0.5%
    • Cancer-related Molecular Pathways

Papers in

    • Cancer-related Molecular Pathways 24
    • Ubiquitin and proteasome pathways 8
    • PI3K/AKT/mTOR signaling in cancer 7

Robert Bookstein

54 papers receiving 8.0k citations

Robert Bookstein's Hit Papers

Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. 1994 · 761 citations
7610+13+26Years since publication4008001.2k

Peers

Robert Bookstein
Comparison fields: 5 of 133
  • Ophthalmology 1.7k
  • Oncology 3.7k
  • Cancer Research 1.3k
  • Molecular Biology 4.3k
  • Genetics 600
Replace John W. Ludlow with:
John W. Ludlow United States
Jin‐Yuh Shew Taiwan
Annelies de Klein Netherlands
Jun Yokota Japan
Naomi Fukai United States
Arupa Ganguly United States
Antje Sucker Germany
Denise Crowley United States
Janice Nigro United States
David Moscatelli United States
Robert Bookstein relative to John W. Ludlow United States John W. Ludlow's profile →
Citations per field
00.5×2×2.6×
John W. Ludlow · 1×
Citations per year

Countries citing papers authored by Robert Bookstein

Since Specialization
Citations

This map shows the geographic impact of Robert Bookstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Bookstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Bookstein more than expected).

Fields of papers citing papers by Robert Bookstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Bookstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Bookstein. The network helps show where Robert Bookstein may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert Bookstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Bookstein Line = papers co-authored together Robert Bookstein links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Human Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence
Hit paper breakdown →
19871204
2
Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy.
Hit paper breakdown →
1994761
3
Suppression of the Neoplastic Phenotype by Replacement of the RB Gene in Human Cancer Cells
Hit paper breakdown →
1988723
4
The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity
Hit paper breakdown →
1987565
5
Inactivation of the Retinoblastoma Susceptibility Gene in Human Breast Cancers
Hit paper breakdown →
1988541
6
Suppression of Tumorigenicity of Human Prostate Carcinoma Cells by Replacing a Mutated RB Gene
Hit paper breakdown →
1990541
7 1990473
8
p53 is mutated in a subset of advanced-stage prostate cancers.
1993320
9 1990299
10 1994212
11
Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.
2002205
12
Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis.
1998197
13 1994174
14
Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer.
1998170
15 1994166
16 1989164
17 2000160
18 1997114
19 1988112
20
Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes.
1999108

About Robert Bookstein

Robert Bookstein is a scholar working on Oncology, Molecular Biology, Ophthalmology, Genetics and Pulmonary and Respiratory Medicine, having authored 54 papers that have together received 8.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (24 papers), Ocular Oncology and Treatments (20 papers), Virus-based gene therapy research (9 papers), Ubiquitin and proteasome pathways (8 papers), Prostate Cancer Treatment and Research (8 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), interferon and immune responses (5 papers) and Genetic factors in colorectal cancer (5 papers). The work is most often cited by research in Ophthalmology (1.7k citations), Oncology (3.7k citations), Cancer Research (1.3k citations), Molecular Biology (4.3k citations) and Genetics (600 citations). Robert Bookstein has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Wen‐Hwa Lee, Jin‐Yuh Shew, Eva Y.-H.P. Lee, Frank Hong, Phang‐Lang Chen, Donal MacGrogan, Peter Scully, Yumay Chen, Theodore Friedmann and David G. Bostwick. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences, Oncogene, Genomics and Genes Chromosomes and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact